Drugs / BIC
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04076423 | Oct 2019 → Jun 2023 | HIV infectious disease | Fundacion SEIMC-GESIDA | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BIC | “BIC / FTC / TAF” NCT04076423 ↗ |
| Route | Oral | “50 mg BIC + 200 mg FTC + 25 mg TAF), orally, once a day” NCT04076423 ↗ |